|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||
| Cash | ||||||||||
| Prepaid expenses | ||||||||||
| Total Current Assets | ||||||||||
| Deferred offering costs | ||||||||||
| Marketable securities held in Trust Account | ||||||||||
| Marketable securities held in Trust Account | ||||||||||
| TOTAL ASSETS | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable and accrued expenses | ||||||||||
| Accrued offering costs | ||||||||||
| Income taxes payable | ||||||||||
| Redemption payable | ||||||||||
| Total Current Liabilities | ||||||||||
| Warrant liabilities | ||||||||||
| Deferred underwriting fee payable | ||||||||||
| Warrant liabilities | ||||||||||
| Deferred underwriting fee payable | ||||||||||
| TOTAL LIABILITIES | ||||||||||
| Class A common stock subject to possible redemption 2,022,043 shares outstanding at redemption value of $10.20 and $10.07 as of June 30, 2023 and December 31, 2022, respectively | ||||||||||
| Stockholders’ Deficit | ||||||||||
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding | ||||||||||
| Common stock value | ||||||||||
| Class A Common Stock | ||||||||||
| Class B Common Stock | ||||||||||
| Total common stock value | ||||||||||
| Class B common stock, $0.0001 par value; 25,000,000 shares authorized; 360,000 shares issued and outstanding, as of March 31, 2023 and December 31, 2022, respectively | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Class A Common Stock | ||||||||||
| Class B Common Stock | ||||||||||
| Total Stockholders’ Deficit | ||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT |
Loading...